Credit Suisse Upgrades Teva Pharma (TEVA) to Outperform; 'Valuation Now a Treat'
Go back to Credit Suisse Upgrades Teva Pharma (TEVA) to Outperform; 'Valuation Now a Treat'| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 12.88 +0.02 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.86 | 52 Week High | $66.55 | |||
| Open | $12.94 | 52 Week Low | $37.82 | |||
| Day High | $12.98 | P/E | N/A | |||
| Day Low | $12.69 | EPS | $0.00 | |||
| Volume | 8,535,164 | |||||
